US Image-Guided Surgical Neuronavigation and EBRT Systems Market
US Image-Guided Surgical Neuronavigation and EBRT Systems Market
$3,750.00
The US image-guided surgical (IGS) neuronavigation and external beam radiation therapy (EBRT) systems market totaled more than $284m in 2015.
Publisher: Meddevicetracker
- Description
- Contents
- Samples
The US image-guided surgical (IGS) neuronavigation and external beam radiation therapy (EBRT) systems market totaled more than $284m in 2015. This market, as defined in this report, includes the following highly sophisticated technologies used in the image guidance and treatment of various neurological conditions:
- image-guided surgical (IGS) neuronavigation systems
- external beam radiation therapy (EBRT) systems used in cranial/brain neurological (“neuro”) procedures
Presently, the scope of common neurosurgical applications for IGS techniques includes biopsy and resection of brain tumors; cyst aspiration; brain abscess; pallidotomy; thalamotomy; shunt placement in hydrocephalus; excision of cerebral tissues implicated in epilepsy-related and other types of seizures; as well as deep brain stimulation (DBS) in movement diseases, such as dystonia and Parkinson’s disease.
There are two categories of radiation therapy: EBRT, which applies the radiation to the tumor externally, and internal radiation therapy, during which radiation is applied internally (brachytherapy). By far the most common form of conventional radiation therapy is EBRT, which commonly delivers radiation from outside the patient’s body using a multi-purpose linear accelerator, or linac, system that is typically configured as a C-arm gantry platform. Presently, EBRT for neuro applications is performed with two types of platforms: cranial-dedicated Gamma Knife systems or stereotactic radiosurgery (SRS), and linac-based systems. EBRT used for applications involving the brain is referred to as SRS, an advanced ablative radiation treatment used to treat tumors and other disorders in the brain. The focus of this report is on cranial applications, or SRS.
Table of Contents
EXECUTIVE SUMMARY…………………………………………………………………………. ES-1
i. Image-guided surgical neuronavigation systems………………………. ES-1
ii. US image-guided surgical neuronavigation systems market ………. ES-2
iii. External beam radiation therapy systems………………………………… ES-2
iv. US external beam radiation therapy systems market ………………… ES-3
v. Combined market ………………………………………………………………… ES-3
vi. Methodology……………………………………………………………………….. ES-6
Exhibit ES-1: US IGS neuronavigation and EBRT systems market forecast, by therapy segment, 2015-20………………………………………………… ES-4
1. IMAGE-GUIDED SURGICAL NEURONAVIGATION SYSTEMS MARKET………………………………………………………………………………………… 1-1
1.1 Image-guided surgical neuronavigation systems…………………………. 1-3
1.1.1 Selected image-guided surgical neuronavigation systems ………………………………………………………………….. 1-5
1.1.1.1 Brainlab ……………………………………………………. 1-5
1.1.1.2 Medtronic………………………………………………….. 1-7
1.1.1.3 Mazor Robotics …………………………………………. 1-8
1.1.1.4 Synaptive Medical ……………………………………. 1-10
1.1.2 Advancements in stereotaxy ……………………………………. 1-11
1.1.2.1 Frame-based stereotactic systems…………………. 1-11
1.1.2.1.1 MRI Interventions ……………………….. 1-12
1.1.2.2 Frameless stereotactic systems …………………….. 1-12
1.1.2.2.1 Brain shift compensation ……………… 1-14
1.1.3 Planning and visualization software ………………………….. 1-14
1.1.3.1 Brainlab ………………………………………………….. 1-14
1.1.3.2 Fiagon AG………………………………………………. 1-15
1.1.3.3 Medtronic………………………………………………… 1-15
1.2 Market analysis ………………………………………………………………………… 1-16
1.3 Competitive analysis …………………………………………………………………. 1-19
Bibliography ………………………………………………………………………………….. 1-21
Exhibit 1-1: Selected characteristics of commonly performed image-guided neurosurgical procedures ………………………………………………………… 1-4
Exhibit 1-2: Brainlab’s Curve image guided surgery system…………………………… 1-6
Exhibit 1-3: Medtronic’s StealthStation surgical imaging and neuronavigation systems ………………………………………………………………………………… 1-9
Exhibit 1-4: US image-guided surgical neuronavigation systems market forecast, 2015-20………………………………………………………………….. 1-17
Exhibit 1-5: US image-guided surgical neuronavigation systems market, share by supplier, 2015 …………………………………………………………. 1-20
2. EXTERNAL BEAM RADIATION THERAPY SYSTEMS MARKET FOR NEUROLOGICAL DISORDERS………………………………………………………… 2-1
2.1 Radiation Therapy Overview ……………………………………………………. 2-1
2.1.1 External beam radiation therapy…………………………………. 2-2
2.1.2 Radiosurgery …………………………………………………………… 2-4
2.1.2.1 Elekta’s Gamma Knife………………………………… 2-5
2.1.2.1.1 Gamma Knife Icon ………………….. 2-8
2.1.2.2 Accuray’s CyberKnife ……………………………….. 2-10
2.1.3 Selected linear accelerator/radiotherapy systems ……….. 2-11
2.1.3.1 Accuray’s TomoTherapy system………………… 2-11
2.1.3.1.1 Radixact Treatment Delivery System………………………………… 2-14
2.1.3.2 Elekta’s Versa HD ……………………………………. 2-14
2.1.3.3 Varian Medical Systems’ radiotherapy systems ………………………………………………….. 2-15
2.2 Emerging Technology……………………………………………………………. 2-18
2.2.1 Elekta’s Atlantic MRI-guided radiation therapy……………. 2-18
2.2.2 Varian Medical Systems’ high-definition radiotherapy and 4pi technology …………………………………………………. 2-19
2.2.3 ViewRay’s MRIdian ………………………………………………… 2-21
2.2.4 Proton therapy……………………………………………………….. 2-23
2.2.4.1 Varian Medical Systems……………………………. 2-24
2.2.4.2 Hitachi America ……………………………………….. 2-25
2.2.4.3 Ion Beam Applications………………………………. 2-27
2.2.4.4 Mevion Medical Systems…………………………… 2-28
2.2.4.5 ProTom International………………………………… 2-29
2.2.4.6 Clinical trials for proton therapy………………….. 2-29
2.3 Market forecast…………………………………………………………………….. 2-29
2.4 Competitive analysis……………………………………………………………… 2-34
Bibliography ………………………………………………………………………………….. 2-36
Exhibit 2-1: Elekta’s Leksell Gamma Knife Icon …………………………………………… 2-9
Exhibit 2-2: Advantages and benefits of the CyberKnife ……………………………… 2-12
Exhibit 2-3: Varian Medical Systems’ TrueBeam Radiotherapy System ………… 2-16
Exhibit 2-4: Advantages of Varian Medical Systems’ ProBeam pencil-beam scanning technology……………………………………………………………… 2-26
Exhibit 2-5: External beam radiation therapy systems market forecast, including estimated cranial/brain (neuro)-attributable revenues, 2015-20 ………………………………………………………………………………. 2-30
Exhibit 2-6: External beam radiation therapy systems market, cranial-brain (neuro) applications, share by supplier, 2015……………………………. 2-35
APPENDIX A: COMPANY LISTING
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Profitability Assessment of Branded Generic Inhalers 
Sign up to the